American Journal of Kidney Diseases
Volume 53, Issue 1 , Pages 70-78 , January 2009

Blood Pressure and Mortality Risk on Peritoneal Dialysis

  • Udaya P. Udayaraj, MD

      Affiliations

    • UK Renal Registry, Southmead Hospital, Bristol, UK
    • Corresponding Author InformationAddress correspondence to Udaya P. Udayaraj, MD, UK Renal Registry, Southmead Hospital, Southmead Rd, Bristol, BS10 5NB UK
    • ,
  • Retha Steenkamp, MSc

      Affiliations

    • UK Renal Registry, Southmead Hospital, Bristol, UK
    • ,
  • Fergus J. Caskey, MD

      Affiliations

    • UK Renal Registry, Southmead Hospital, Bristol, UK
    • Richard Bright Renal Unit, Southmead Hospital, Bristol, UK
    • ,
  • Chris Rogers, PhD

      Affiliations

    • Bristol Heart Institute, University of Bristol, Bristol, UK
    • ,
  • Dorothea Nitsch, MD, MSc

      Affiliations

    • Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
    • ,
  • David Ansell, MBBS

      Affiliations

    • UK Renal Registry, Southmead Hospital, Bristol, UK
    • ,
  • Charles R.V. Tomson, DM

      Affiliations

    • UK Renal Registry, Southmead Hospital, Bristol, UK
    • Richard Bright Renal Unit, Southmead Hospital, Bristol, UK

Received 23 August 2007 ,Accepted 26 August 2008.

References 

  1. Gasowski J, Fagard RH, Staessen JA, et al. Pulsatile blood pressure component as predictor of mortality in hypertension: A meta-analysis of clinical trial control groups. J Hypertens. 2002;20:145–151
  2. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291–1297
  3. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world (Seven Countries Study Research Group). N Engl J Med. 2000;342:1–8
  4. Li Z, Lacson E, Lowrie EG, et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis. 2006;48:606–615
  5. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: The 58th Annual Fall Conference and Scientific Sessions. Hypertension. 2005;45:811–817
  6. Salem MM. Hypertension in the haemodialysis population: Any relationship to 2-years survival?. Nephrol Dial Transplant. 1999;14:125–128
  7. Port FK, Hulbert-Shearon TE, Wolfe RA, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999;33:507–517
  8. Zager PG, Nikolic J, Brown RH, et al. “U” Curve association of blood pressure and mortality in hemodialysis patients (Medical Directors of Dialysis Clinic, Inc). Kidney Int. 1998;54:561–569
  9. Duranti E, Imperiali P, Sasdelli M. Is hypertension a mortality risk factor in dialysis?. Kidney Int Suppl. 1996;55:S173–A174
  10. Salem MM, Bower J. Hypertension in the hemodialysis population: Any relation to one-year survival?. Am J Kidney Dis. 1996;28:737–740
  11. Agarwal R. Hypertension and survival in chronic hemodialysis patients—Past lessons and future opportunities. Kidney Int. 2005;67:1–13
  12. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996;49:1379–1385
  13. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793–808
  14. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis. 2003;42:864–881
  15. Iseki K, Miyasato F, Tokuyama K, et al. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int. 1997;51:1212–1217
  16. Selby NM, McIntyre CW. The acute cardiac effects of dialysis. Semin Dial. 2007;20:220–228
  17. Selby NM, Burton JO, Chesterton LJ, McIntyre CW. Dialysis induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol. 2006;1:1216–1225
  18. Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW. Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis. 2006;47:830–841
  19. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66:1212–1220
  20. Lynn KL, McGregor DO, Moesbergen T, Buttimore AL, Inkster JA, Wells JE. Hypertension as a determinant of survival for patients treated with home dialysis. Kidney Int. 2002;62:2281–2287
  21. Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK. The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2005;20:1693–1701
  22. Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ. Risk factors for early mortality in U.S. peritoneal dialysis patients: Impact of residual renal function. Perit Dial Int. 2002;22:371–379
  23. Ates K, Nergizoglu G, Keven K, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001;60:767–776
  24. Jager KJ, Merkus MP, Dekker FW, et al. Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD Study Group). Kidney Int. 1999;55:1476–1485
  25. Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5:2725–2731
  26. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure (Collaborative Transplant Study). Kidney Int. 1998;53:217–222
  27. Mange KC, Feldman HI, Joffe MM, Fa K, Bloom RD. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol. 2004;15:187–193
  28. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis. 2004;43:1071–1081
  29. Caliskan Y, Oflaz H, Demirturk M, Yazici H. Coronary flow reserve changes in hemodialysis patients and renal transplant recipients. Nephrol Dial Transplant. 2007;22:339A;(abstr)
  30. Ansell D, Feest T. The Sixth Annual Report. In: Bristol, UK: UK Renal Registry; 2003;p. 3–14
  31. Tomson C, Udayaraj U, Gilg J, Ansell D. Comorbidities in UK patients at the start of renal replacement therapy. Nephrol Dial Transplant. 2007;22:58–68
  32. Nanchahal K, Mangtani P, Alston M, dos Santos Silva I. Development and validation of a computerized South Asian Names and Group Recognition Algorithm (SANGRA) for use in British health-related studies. J Public Health Med. 2001;23:278–285
  33. Roderick PJ, Raleigh VS, Hallam L, Mallick NP. The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health. 1996;50:334–339
  34. Raleigh VS. Diabetes and hypertension in Britain's ethnic minorities: Implications for the future of renal services. BMJ. 1997;314:209–213
  35. Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332:1080
  36. Flegal KM, Keyl PM, Nieto FJ. Differential misclassification arising from nondifferential errors in exposure measurement. Am J Epidemiol. 1991;134:1233–1244
  37. Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int. 2000;58:2147–2154
  38. Stidley CA, Hunt WC, Tentori F, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol. 2006;17:513–520
  39. Tomita J, Kimura G, Inoue T, et al. Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis. 1995;25:405–412
  40. De Lima JJ, Vieira ML, Abensur H, Krieger EM. Baseline blood pressure and other variables influencing survival on haemodialysis of patients without overt cardiovascular disease. Nephrol Dial Transplant. 2001;16:793–797
  41. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant. 2002;17:1085–1092
  42. Carfray A, Patel K, Whitaker P, Garrick P, Griffiths GJ, Warwick GL. Albumin as an outcome measure in haemodialysis in patients: The effect of variation in assay method. Nephrol Dial Transplant. 2000;15:1819–1822
  43. Ansell D, Feest T. The Third Annual Report. In: Bristol, UK: UK Renal Registry; 2000;p. 113–124
  44. Ragosta M, Samady H, Isaacs RB, Gimple LW, Sarembock IJ, Powers ER. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J. 2004;147:1017–1023
  45. Tok D, Gullu H, Erdogan D, et al. Impaired coronary flow reserve in hemodialysis patients: A transthoracic Doppler echocardiographic study. Nephron Clin Pract. 2005;101:c200–c206

 Originally published online as doi:10.1053/j.ajkd.2008.08.030 on November 25, 2008.

PII: S0272-6386(08)01422-4

doi: 10.1053/j.ajkd.2008.08.030

American Journal of Kidney Diseases
Volume 53, Issue 1 , Pages 70-78 , January 2009

Article Tools

* Image Usage & Resolution